• Users Online:293
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

 Table of Contents  
Year : 2019  |  Volume : 8  |  Issue : 5  |  Page : 350-351

EUS-guided botulinum toxin injection into the pyloric sphincter for the treatment of gastroparesis

Department of Gastroenterology, Hepatology and Nutrition-Unit 1466, UT MD Anderson Cancer Center, Houston, Texas 77030-4009, USA

Date of Submission04-Jan-2019
Date of Acceptance05-Mar-2019
Date of Web Publication20-Jun-2019

Correspondence Address:
Dr. Manoop S Bhutani
Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Unit 1466, 1515 Holcombe Blvd., Houston, Texas 77030
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/eus.eus_22_19

Rights and Permissions

How to cite this article:
Bhutani MS. EUS-guided botulinum toxin injection into the pyloric sphincter for the treatment of gastroparesis. Endosc Ultrasound 2019;8:350-1

How to cite this URL:
Bhutani MS. EUS-guided botulinum toxin injection into the pyloric sphincter for the treatment of gastroparesis. Endosc Ultrasound [serial online] 2019 [cited 2022 Nov 27];8:350-1. Available from: http://www.eusjournal.com/text.asp?2019/8/5/350/260853

A 51-year-old man after esophagectomy for distal esophageal cancer developed severe gastroparesis. His symptoms of gastroesophageal reflux, chest pain, early satiety, and fullness in the chest were persistent despite medical treatment. An esophagogastroduodenoscopy (EGD) with pyloric botulinum toxin injection with a balloon dilation resulted in “>80%” symptomatic benefit for 3 months with relapse of significant symptoms thereafter. On repeat EGD, food was found in the gastric body despite the patient being fasting consistent with delayed gastric emptying. The pylorus looked normal but appeared to contract “vigorously” suggesting pylorospasm [Figure 1]. A linear echoendoscope was passed to the duodenum bulb where the normal duodenal wall thickness was 2 mm (normal) [Figure 2]. As the echoendoscope was withdrawn to the level of the pylorus at the pyloric sphincter, it revealed a stark change with a thickness of 7–8 mm. A 25G endoscopic ultrasound-guided fine-needle aspiration needle was inserted into the muscular region of the pyloric sphincter deeper to the mucosa/submucosa but superficial to serosa. The pyloric sphincter was precisely injected with a total 100 U (25 U/mL in 4 quadrants) of botulinum toxin [Figure 3] followed by pyloric balloon dilation to 20 mm, without immediate or delayed adverse effects. The patient again had significant response to treatment which lasted for twice the duration for 6 months.
Figure 1: Pyloric sphincter seen during EGD that looked normal but appeared to contract vigorously during endoscopy suggesting pylorospasm

Click here to view
Figure 2: Normal duodenal bulb wall by EUS with a thickness of about 2 mm

Click here to view
Figure 3: The pyloric sphincter as seen by EUS with total thickness of 7–8 mm with the needle implanted under EUS guidance in the muscularis propria

Click here to view

The standard technique of botulinum toxin injection into the pylorus is done during EGD with an injection needle without any additional imaging guidance.[1],[2] The drug may be delivered mostly in the submucosa or only partly into the muscularis propria. A technique for more precise delivery of the drug to the muscularis propria could potentially improve the duration (as seen in this patient) and degree of response. Further prospective studies of this technique would be worthwhile.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published and due efforts will be made to conceal his identity, but anonymity cannot be guaranteed.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Ezzeddine D, Jit R, Katz N, et al. Pyloric injection of botulinum toxin for treatment of diabetic gastroparesis. Gastrointest Endosc 2002;55:920-3.  Back to cited text no. 1
Su A, Conklin JL, Sedarat A. Endoscopic therapies for gastroparesis. Curr Gastroenterol Rep 2018;20:25.  Back to cited text no. 2


  [Figure 1], [Figure 2], [Figure 3]

This article has been cited by
1 Stigma experiences of patients living with gastroparesis
Tiffany H. Taft,Meredith R. Craven,Emerald P. Adler,Madison Simons,Linda Nguyen
Neurogastroenterology & Motility. 2021;
[Pubmed] | [DOI]
2 Advances in the diagnosis and treatment of achalasia of the cardia: A review
Baozhen Zhang,Yidan Wang,Ye Liao,Jingjing Zhang,Yufan Wu,Tingyue Xiao,Yue Zhang,Yiwen Bao,Hongyu Qiu,Siyu Sun,Jintao Guo
Journal of Translational Internal Medicine. 2021; 9(1): 24
[Pubmed] | [DOI]
3 Advances in the prevention and treatment of esophageal stricture after endoscopic submucosal dissection of early esophageal cancer
Yue Zhang,Baozhen Zhang,Yidan Wang,Jingjing Zhang,Yufan Wu,Tingyue Xiao,Ye Liao,Yiwen Bao,Hongyu Qiu,Siyu Sun,Jintao Guo
Journal of Translational Internal Medicine. 2020; 8(3): 135
[Pubmed] | [DOI]


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

  In this article
   Article Figures

 Article Access Statistics
    PDF Downloaded149    
    Comments [Add]    
    Cited by others 3    

Recommend this journal